Home Newsfeeds Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Top 2 Real Estate Stocks That Are Set To Fly In Q4

By Avi Kapoor

December 22, 8:33 AM

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

ASPS

HC Wainwright & Co. Maintains Buy on Harpoon Therapeutics, Lowers Price Target to $7

By Benzinga Newsdesk

August 15, 6:44 AM

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Harpoon Therapeutics (NASDAQ:HARP) with a Buy and lowers the price target from $18 to $7.

HARP

Top 5 Tech And Telecom Stocks You’ll Regret Missing This Quarter

By Lisa Levin

June 15, 7:43 AM

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.

BREA

Morgan Stanley Identifies Top ‘Alpha’ Stocks In APAC, One With Potential 28% Upside

By Benzinga Neuro

April 15, 11:12 PM

The global investment bank Morgan Stanley has recently released a list of top "alpha" stocks in the Asia-Pacific region, which includes a South Korean bank with a potential 28% upside.

BABA

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Related Posts

Top 2 Real Estate Stocks That Are Set To Fly In Q4

HC Wainwright & Co. Maintains Buy on Harpoon Therapeutics, Lowers Price Target to $7

Top 5 Tech And Telecom Stocks You’ll Regret Missing This Quarter

Morgan Stanley Identifies Top ‘Alpha’ Stocks In APAC, One With Potential 28% Upside